Screening for a Potential Therapeutic Agent from the Herbal Formula in the 4^th Edition of the Chinese National Guidelines for the Initial-Stage Management of COVID-19 via Molecular Docking

Table 1

PDBePISA interface result of SARS-CoV-2 spike glycoprotein and angiotensin-converting enzyme 2 (chain D).

Structure 1	Structure 2	Interface area (A^2)	ΔiG (kcal/mol)	ΔiG ( value)
Chain B	Chain C	5285.6	−45.9	0.707
Chain A	Chain B	5263.4	−42.8	0.722
Chain A	Chain C	5248.1	−41.7	0.781
Chain D (ACE2)	Chain B	830.3	−11.2	0.341
Chain D (ACE2)	Chain C	712.7	−5.3	0.666